Abstract
This article reviews the characteristics of the main fluoroquinolones used in dentistry (ciprofloxacin, levofloxacin and moxifloxacin), including pharmacokinetic/ pharmacodynamic parameters, susceptibility profiles of oral bacteria and clinical trials on their efficacy in dental practice. It seems that some of these antibiotics might represent a safe alternative in patients with allergy, intolerance, or lack of response to beta-lactams.
Keywords: Antimicrobial susceptibility, ciprofloxacin, fluoroquinolones, focal infection, levofloxacin, moxifloxacin, oral infection, oral pathogens
Mini-Reviews in Medicinal Chemistry
Title: Efficacy of Fluoroquinolones Against Pathogenic Oral Bacteria
Volume: 9 Issue: 10
Author(s): V. Nunez Otero, J. Limeres Posse, I. Tomas Carmona and P. Diz Dios
Affiliation:
Keywords: Antimicrobial susceptibility, ciprofloxacin, fluoroquinolones, focal infection, levofloxacin, moxifloxacin, oral infection, oral pathogens
Abstract: This article reviews the characteristics of the main fluoroquinolones used in dentistry (ciprofloxacin, levofloxacin and moxifloxacin), including pharmacokinetic/ pharmacodynamic parameters, susceptibility profiles of oral bacteria and clinical trials on their efficacy in dental practice. It seems that some of these antibiotics might represent a safe alternative in patients with allergy, intolerance, or lack of response to beta-lactams.
Export Options
About this article
Cite this article as:
Otero Nunez V., Posse Limeres J., Carmona Tomas I. and Dios Diz P., Efficacy of Fluoroquinolones Against Pathogenic Oral Bacteria, Mini-Reviews in Medicinal Chemistry 2009; 9 (10) . https://dx.doi.org/10.2174/138955709789055243
DOI https://dx.doi.org/10.2174/138955709789055243 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Central Nervous System Manifestations in Systemic Lupus Erythematosus
Current Rheumatology Reviews Chest Pain in Children
Current Pediatric Reviews Instructions from the Vascular System - Directing Neural Stem Cell Fate in Health and Disease
Current Medicinal Chemistry Anti-Selectin Therapy for the Treatment of Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Update on Childhood Brucellosis
Recent Patents on Anti-Infective Drug Discovery Proteomic Analysis of Cerebrospinal Fluid: A Search for Biomarkers of Neuropsychiatric Systemic Lupus Erythematosus
Current Proteomics Antimicrobial Development in the Era of Emerging Resistance
Mini-Reviews in Medicinal Chemistry Drug Discovery in Enteroviral Infections
Infectious Disorders - Drug Targets Diagnosis and Treatment of Paraneoplastic Neurological Syndromes
Current Clinical Pharmacology FDG-PET/CT Imaging of Infected Bones and Prosthetic Joints
Current Molecular Imaging (Discontinued) Childhood Infectious Encephalitis: An Overview of Clinical Features, Investigations, Treatment, and Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery Autoimmune Channelopathies of the Nervous System
Current Neuropharmacology Extrapulmonary Tuberculosis- Its Management and Control
Current Drug Therapy Image Guided Biopsy of Musculoskeletal Lesions with Low Diagnostic Yield
Current Medical Imaging An Update on Autoinflammatory Diseases
Current Medicinal Chemistry The Role of Viruses in Neurodegenerative and Neurobehavioral Diseases
CNS & Neurological Disorders - Drug Targets Humanized Cobra Venom Factor: Experimental Therapeutics for Targeted Complement Activation and Complement Depletion
Current Pharmaceutical Design The Changing Landscape of Voltage-Gated Calcium Channels in Neurovascular Disorders and in Neurodegenerative Diseases
Current Neuropharmacology Innovation in Contrast Agents for Magnetic Resonance Imaging
Current Medical Imaging Diagnostic Value of 99m Tc- Labeled-Ubiquicidin 29-41 (99m Tc-UBI) Scan in the Diagnosis of Vertebral Osteomyelitis
Current Medical Imaging